Post by Johnson & Johnson Innovative Medicine ANZ

Innovation, collaboration, and advocacy are at the heart of what we do – and this commitment has been front and centre during Lung Cancer Awareness Month. Each year, around 15,000 Australians are diagnosed with lung cancer, which still has one of the lowest survival rates. That’s why we’re proud of our team members who joined Shine a Light on Lung Cancer, a nationwide event that brings communities together to raise awareness and funds for research and support that can transform lives. We also supported Lung Foundation Australia at the Parliamentary Friends of Lung Health event in Canberra, celebrating the success of the National Lung Cancer Screening Program and highlighting the profound impact lung disease has on patients and families. Let’s keep the conversation going. Together, we can reduce stigma, drive early detection, and create a future where lung cancer is treated effectively.   #LungCancerAwareness #ShineALight #JNJ #BetterOutcomes   Pollyanna Clayton, Ilaria Fossati, Erica McAuley-Clark, Natasha Georgiou, Jade Caffrey